Archive for the ‘Gene Therapy Research’ Category

Islands at Risk Genetic Engineering in Hawaii GMO Part 3
From:DocumentaireOnlineViews:0 0ratingsTime:09:41More inPeople Blogs

Originally posted here:
Islands at Risk Genetic Engineering in Hawaii GMO Part 3 - Video

Invitation Stop Monsantoizing our Food and Agriculture
Workshop on: MONSANTO, A THREAT TO HEALTH, ENVIRONMENT HUMAN RIGHTS Sunday, 9th December 2012 starting at 10 am Venue: Seminar Hall No 1, ICSSR Complex, Panjab University Campus, Chandigarh All are invited. Building People #39;s resistance to the Poisoning of our Food Future of Food in the Era of proprietary seed technologies is under severe threat. Monsanto is a dangerous Agro-Chemical, Seed and Genetic Engineering Giant. Monsanto is entering Punjab on the invitation of Government of Punjab. Monsanto is invited here to establish Research Centre in Punjab Monsanto #39;s markets expanding with taxpayers #39; funds in recent past Remember the drubbing that they got from KRRS in Karnataka Monsanto is known for its anti-Farmer, anti-People, anti-Nature products and operations world-over. It has not hesitated to use unethical and illegal bribing of decision-makers to get approvals for their products elsewhere. It has chased farmers and other for so-called royalties upto the import shores in Europe, from developing countries. It has sued and jailed farmers in the name of patent infringement. It is a profit-hungry corporation that reportedly had set as its objective control over all food grown. Monsanto controls most of the GM crop cultivation in the world -- this is a technology that is known to have health, environmental and trade impacts all over the world. Monsanto is our modern-day East India Company, bringing food and agricultural imperialism knocking at our doors. Let us oppose ...From:Aawaaz dotnetViews:0 0ratingsTime:00:36More inNonprofits Activism

See the rest here:
Invitation Stop Monsantoizing our Food and Agriculture - Video

Exclusive Genetics at #FanFest w/Billy Jaynes (Matt Jane)
From:matthew rappaportViews:0 2ratingsTime:16:18More inEntertainment

View post:
Exclusive Genetics at #FanFest w/Billy Jaynes (Matt

VNT Genetics 3
descriptionFrom:abby osmunViews:1 0ratingsTime:01:22More inScience Technology

Link:
VNT Genetics 3 - Video

Single Cardiomyocyte beating
Beating cardiomyocyte generated from human iPS after monolayer dissociation. Day 29 of differentiation / Day 12 after monolayer dissociation. Laboratory of Genetics and Molecular CardiologyFrom:Diogo G BiagiViews:0 0ratingsTime:00:07More inPeople Blogs

The rest is here:
Single Cardiomyocyte beating - Video

Bacterial Genetics
Foundations of Bacterial GeneticsFrom:DocterindotcomViews:4 0ratingsTime:11:04More inEducation

Go here to see the original:
Bacterial Genetics - Video

Treeing Walker Coonhound doing his thing
My rescued Walker Coonhound Cooper doing what he was bred for, although this is with a squirrel. Really fun to watch the instincts and genetics kick in from time to time.From:mcfarl58Views:0 0ratingsTime:00:46More inPeople Blogs

See the original post here:
Treeing Walker Coonhound doing his thing - Video

Hulk Trailer 2003
Bruce Banner, a genetics researcher with a tragic past, suffers an accident that causes him to transform into a raging green monster when he gets angry.From:Benjamin RodriguezViews:0 0ratingsTime:02:30More inPeople Blogs

Go here to read the rest:
Hulk Trailer 2003 - Video

Seeing the Unseen in Cell Machinery by Label-free Spectroscopic Imaging
webinar Elsevier Dr. Ji-Xin Cheng Associate Professor, Weldon School of Biomedical Engineering Moderator: Kaia Motter Publisher, Genetics IIFrom:TheEvgenkenViews:1 0ratingsTime:58:04More inScience Technology

See more here:
Seeing the Unseen in Cell Machinery by Label-free Spectroscopic Imaging - Video

Genetics with a Concentration of Clones
~School Science Project~ Featuring Naila, Aleeah, and Joan.From:MsJoan1999Views:0 0ratingsTime:07:22More inMusic

Visit link:
Genetics with a Concentration of Clones - Video

SALT LAKE CITY, Dec. 7, 2012 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (MYGN) announced today that a presentation entitled "Homologous recombination deficiency (HRD) score predicts pathologic response following neoadjuvant platinum-based therapy in triple-negative and BRCA1/2 mutation-associated breast cancer (BC)," was presented on Friday, December 7, 2012 at the CTRC-AACR San Antonio Breast Cancer Symposium in San Antonio, Texas. The study demonstrates that Myriad's HRD test strongly predicts which primary tumors will respond to platinum-based combination therapy in patients with triple-negative breast cancer.

Triple-negative breast cancer describes breast tumors that lack estrogen receptor, progesterone receptor and HER2. This type of breast cancer tends to be more aggressive than other subtypes of breast cancer and has not been amenable to targeted therapies. The platinum class of drugs kill tumors by causing DNA damage inside the tumor and may be particularly effective against tumors that have lost their ability to repair DNA.

Researchers at Stanford University School of Medicine and Myriad Genetics studied the pathologic response of tumors in patients with triple-negative breast cancer to a carboplatin-based therapy and showed that the HRD test can significantly predict patient response to such therapy. 70% of patients with an HRD score >=10 responded to the carboplatin treatment, compared to only 20% of patients with an HRD score < 10 (p=0.0001). Using the HRD test instead of BRCA status identified more than 3 times as many patients as likely responders. The HRD test may prove to be a very important tool in guiding the treatment of patients with triple-negative breast cancer.

"DNA repair deficiency is believed to be a property of a significant number of triple-negative breast tumors," said Dr. James Ford of Stanford University School of Medicine, the senior author of the study. "The HRD score has enabled us to effectively identify the majority of responders with high accuracy."

Many breast tumors are believed to be deficient in DNA repair capacity. Myriad's HRD test is designed to predict patient response to DNA damaging agents such as platinum drugs and PARP inhibitors that may be more effective against these subsets of breast cancer. With further research, the use of the HRD test may become an important tool to guide treatment decisions in all breast cancer patients.

About Myriad Genetics

Myriad Genetics is a leading molecular diagnostic company dedicated to making a difference in patients' lives through the discovery and commercialization of transformative tests to assess a person's genetic risk of developing disease, guide treatment decisions and assess risk of disease progression and recurrence. Myriad's portfolio of molecular diagnostic tests are based on an understanding of the role genes play in human disease and were developed with a commitment to improving an individual's decision making process for monitoring and treating disease. Myriad is focused on strategic directives to introduce new products, including companion diagnostics, as well as expanding internationally. For more information on how Myriad is making a difference, please visit the Company's website: http://www.myriad.com

Myriad, the Myriad logo, BRACAnalysis, Colaris, Colaris AP, Melaris, TheraGuide, Prezeon, OnDose, Panexia and Prolaris are trademarks or registered trademarks of Myriad Genetics, Inc. in the United States and foreign countries. MYGN-G

Safe Harbor Statement

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995,including statements relating to the ability of the HRD test to predict which primary tumors will respond to platinum-based combination therapy in patients with triple-negative breast cancer; whether the HRD test will become a important tool to guide the treatment of patients with triple-negative breast cancer and in all breast cancer patients; and the Company's strategic directives under the caption "About Myriad Genetics". These "forward-looking statements" are based on management's current expectations of future events and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by forward-looking statements. These risks and uncertainties include, but are not limited to: the risk that sales and profit margins of our existing molecular diagnostic tests and companion diagnostic services may decline or will not continue to increase at historical rates; the risk that we may be unable to expand into new markets outside of the United States; the risk that we may be unable to develop or achieve commercial success for additional molecular diagnostic tests and companion diagnostic services in a timely manner, or at all; the risk that we may not successfully develop new markets for our molecular diagnostic tests and companion diagnostic services, including our ability to successfully generate revenue outside the United States; the risk that licenses to the technology underlying our molecular diagnostic tests and companion diagnostic services and any future products are terminated or cannot be maintained on satisfactory terms; risks related to delays or other problems with manufacturing our products or operating our laboratory testing facilities; risks related to public concern over genetic testing in general or our tests in particular; risks related to regulatory requirements or enforcement in the United States and foreign countries and changes in the structure of healthcare payment systems; risks related to our ability to obtain new corporate collaborations and acquire new technologies or businesses on satisfactory terms, if at all; risks related to our ability to successfully integrate and derive benefits from any technologies or businesses that we acquire; the development of competing tests and services; the risk that we or our licensors may be unable to protect the proprietary technologies underlying our tests; the risk of patent-infringement and invalidity claims or challenges of our patents; risks of new, changing and competitive technologies and regulations in the United States and internationally; and other factors discussed under the heading "Risk Factors" contained in Item 1A in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, as well as any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10-Q or Current Reports on Form 8-K. All information in this press release is as of the date of the release, and Myriad undertakes no duty to update this information unless required by law.

Read the original post:
Myriad Genetics' HRD Test Predicts Response to Platinum Therapy in Triple-Negative Breast Cancer

Gene Therapy (Advanced Biotechnology Project)
james73394 #39;s shared video file.From:James ReisViews:0 0ratingsTime:03:01More inScience Technology

Read the rest here:
Gene Therapy (Advanced Biotechnology Project) - Video

All of us Guinea Pigs Now
From 2009 to 2011, under conditions of total secrecy, Professor Séralini and The *CRIIGEN lead an experience with unsuspected consequences. It #39;s the world #39;s longest-lasting experiment: the first independent study of a *GMO and the herbicide Roundup. The conclusions are appalling ... After the terrible accident at Chernobyl, the invisible radioactivity reappear en march 2011, with the Fukushima Daiichi nuclear accident. All over the world, 443 nuclear power plants are in activity. GMO #39;s, NUCLEAR POWER: we use and accept those technologies without health or environmental independent tests. Are we all of us guinea-pigs now? *Committee for Research and Independent Information on Genetic Engineering *The Monsanto mice NK 603From:Wide HouseViews:0 0ratingsTime:01:48More inNonprofits Activism

See the original post here:
All of us Guinea Pigs Now - Video

SynBio Talks: What is Synthetic Biology? by Thomas Folliard
Thomas Folliard, currently studying Synthetic Biology MRes at UCL, gives a short introduction to Synthetic Biology and explains the main principles: How Synthetic Biology builds upon genetic engineering, and how principles of abstraction and standardization allow the construction of complex new genetic circuitsFrom:SynBioSocViews:10 1ratingsTime:08:52More inScience Technology

Visit link:
SynBio Talks: What is Synthetic Biology? by Thomas Folliard - Video

Genetic Engineering - Ethos, Logos, and Pathos (The Colbert Report Parody)
Video project created for Dr. Alyana Heinonen #39;s WRD 111 class, University of Kentucky. Written by: Adam Brewer, Lisa Patterson, Laken Greene, and Hana Hafer Editor: Adam BrewerFrom:GeneticEngineering12Views:0 0ratingsTime:06:51More inPeople Blogs

Read this article:
Genetic Engineering - Ethos, Logos, and Pathos (The Colbert Report Parody) - Video

Professor Ulrich Mueller Speaks on the Genetics of Hearing
Ulrich Mueller, PhD, professor and director of the Dorris Neuroscience Center at The Scripps Research Institute, discusses the genetics of hearing and his recent paper in the journal Cell.From:ScrippsResearchViews:5 0ratingsTime:03:55More inScience Technology

Read more here:
Professor Ulrich Mueller Speaks on the Genetics of Hearing - Video

Revelation TV Q A show with John Mackay - Creationism (Part 2)
http://www.revelationtv.com Join Revelation TV Founder Howard Conder and Creationist John Mackay for this Q A special on Creation. John Mackay is an international speaker and is the Australian Director of Creation Research. He has been lecturing on the subject of origins and doing field research worldwide for the last 30 years. Visit his website here http://www.askjohnmackay.com In March 2005 John debated the UK #39;s leading theistic evolutionist, Dr John Polkinghorne in a lively clash, hosted by popular BBC commentator Roger Phillips. The entire debate was professionally filmed and adds to the long list of John #39;s debates against leading evolutionists. During 2004, John was asked to debate 3 New Zealand professors at once. His opposition included Dr David Penny who had just been awarded NZ #39;s highest science prize in genetics. In the preceding 4 years, John debated such notable opponents as Cambridge geologist Dr Trevor Emmet at the Mumford Lecture Theatre Cambridge, Geology Professor Dr Tim Astin at Reading University and Harvard University Professor Chris Di Carlos at Guelph University, Canada. During January 1999 he was pitted against Dr Eugenie Scott, head of the National Center for Science in the USA.From:rtveuropeViews:9 1ratingsTime:58:01More inScience Technology

See the rest here:
Revelation TV Q

Rudolph the White-Eyed Drosophila
The men of our Honors Genetics singing a carol written by Andrew Engle.From:KRSeibertViews:0 0ratingsTime:01:05More inComedy

Visit link:
Rudolph the White-Eyed Drosophila - Video

More Questions for Inmendham (re: DNA)
A response to this video: http://www.youtube.com 1. I was wondering if Inmendham has heard about Gregor Mendel, the father of modern genetics. By his experiments with peas, he established that allelles of genes are expressed in certain percentages in future generations, so characteristics (traits) do not blend, do not dilute (otherwise we would all be hermaphrodites!). I assume that in Inmendham #39;s thought experiment the dog has a new allelle for hearing with four ears, instead of with two ears. Sub-questions: Has he heard of symbiosis, or mutualism, when both organisms profit from their association? Has he heard of cooperation (ants, for ex.)? 2. Has he read Richard Dawkins #39; book "The Selfish Gene"? Or has he read only the title? Because he often mentions the title, but never shows if he is acquainted with the content of the book.From:dewinthemorningViews:1 1ratingsTime:05:21More inNonprofits Activism

Go here to see the original:
More Questions for Inmendham (re: DNA) - Video

New genetics/420 grow off
18 and older only. Medical cannabis channel. Still no mic :/ Just showing some of my new strains i will be introducing into my nex veg cycle. Anyone have any comments about these strains or reccomendations please let me know! peace n pot 13% #39;er/DOLFrom:Dank HerbViews:1 1ratingsTime:03:22More inEducation

Continue reading here:
New genetics/420 grow off - Video

Golden Rice is Who You Are
Extra Credit Genetics Project -Sorry for the poor quality, iPhoto doesn #39;t take great videos. Lyrics (To whoever wrote the original, I apologize for mangling your beautiful lyrics) Sometimes, daff #39;dils and soil bacterium Carry vit #39;mins that we claim to need When genes we #39;ve hidden or have no loci Have now been given and will arrive E #39;quipped with a new sticky end You know what #39;s happened You know what #39;s happened to rice And who #39;d #39;ve thought that restriction enzyme That we #39;ve been cloning all this time Waiting until the host arrived And always bound to me And who would have thought after all this time That rice is the one you #39;re creating Now undisguised, the host that survives Displays what you want from me I never wanted to give my DNA Who ever thought it would matter any way? Your searching inside this chain Finding fragments of a gene Never sure you #39;d ever know what it means It #39;s the chemists in the lab That genes never thought they #39;d meet It #39;s their hands that picked them up When they #39;re living in the plant It #39;s their hands that cut the ends It #39;s the plasmid that was shared When you thought alleles were lost Here #39;s the gene that wasn #39;t there You can run from all the pipets but never get that far For in the end they #39;ll find you For this is who you are Change one group, change one line Nothing #39;s going to be the same Change one loss, change one cut Everything is rearranged Every part, yours or mine lost inside our DNA If you look there in time you #39;ll find it in Find it in ...From:Tahquamenon RiverViews:0 0ratingsTime:04:41More inPeople Blogs

See the article here:
Golden Rice is Who You Are - Video

Eric Simon
Eric J. Simon, Ph.D. is an Associate Professor in the Department of Biology and Health science at New England College in Henniker, NH. There, he teaches introductory biology to both science majors and non-science majors, as well as genetics, microbiology, molecular biology, and careers in science. He received his Ph.D. in biochemistry from Harvard University and MA and BA degrees in biology from Wesleyan University. Eric lives in rural New Hampshire with his wife, 2 boys, Jack the dog, and a few dozen chickens.From:pearsonheViews:2 0ratingsTime:12:17More inFilm Animation

Read more here:
Eric Simon - Video

Kelly Hogan
Kelly Hogan is a faculty member in the Biology Department at the University of North at Chapel Hill. She teaches large introductory courses at UNC, including a one semester mixed majors biology course and a one semester introduction to genetics. She also teaches a non-majors course on current biological issues and a service learning course related to blood donation. She utilizes technology with her students, such as cell phones as clickers and online homework and discussions. Her research currently focuses on how highly structured active learning and online homework affects student success, especially for underrepresented minority and first generation college students.From:pearsonheViews:2 0ratingsTime:16:52More inFilm Animation

Continue reading here:
Kelly Hogan - Video

Group #5
Animal Genetics and Breeding Class ProjectFrom:PinkInky6Views:0 0ratingsTime:14:14More inEntertainment

Read more here:
Group #5 - Video

Bad Genetics Practice
From:Matt AllardViews:2 0ratingsTime:14:32More inPeople Blogs

Originally posted here:
Bad Genetics Practice - Video